About the Company
We do not have any company description for FENNEC PHARMACEUTICALS INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on FENNEC PHARMACEUTICALS INC.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 19, 2025 Operator: Good morning, ladies and gentlemen, and welcome to Fennec ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
NasdaqCM:FENC 1 Year Share Price vs Fair Value Explore Fennec Pharmaceuticals's Fair Values from the Community ...
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community ...
How Many Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares Have Insiders ...
So before you buy or sell Fennec Pharmaceuticals Inc. (NASDAQ:FENC), you may well want to know whether insiders have been buying or selling.
Fennec Pharmaceuticals Inc. (FENC) - Yahoo Finance
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany ~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, ...
Intech Investment Management LLC Acquires Shares of 10,988 Fennec ...
Intech Investment Management LLC bought a new position in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) during the 4th quarter, according to the company in its most recent disclosure ...
Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call Transcript
Fennec Pharmaceuticals Inc. ( NASDAQ: FENC) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Jeffrey S. Hackman - CEO & Director Robert C. Andrade - Chief Financial Officer ...
Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community Pract ...
Fennec Pharmaceuticals Inc. (FENC) - Yahoo Finance
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript Published on August 10, 2023 at 12:53 pm by Insider Monkey Transcripts in News, Transcripts Page 1 of 2 Next >> ...
Fennec Pharmaceuticals Inc. (FENC) - Yahoo Finance
Company to Also Participate in 2024 Wedbush PacGrow Healthcare ConferenceRESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a ...
Fennec Pharmaceuticals Inc. (FENC) Q2 2023 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ETCompany ParticipantsRobert Andrade - Chief Financial ...
Similar Companies
Loading the latest forecasts...